PI3KInhibitorpi3kinhibitor

Citalopram

By

Citalopram

Product: BGB-3111

Identifier : DBSNPE000046
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Glutamate receptor ionodivopic, kainate 2
Gene Name : GRIK2
UniProt ID : Q13002
Defining Change(s) :

  • C Allele, homozygote (rs2518224 )

Allele Name : Not Available
Genotype(s) : (C;C)
Type(s) : ADR Directly Studied
Groups : Not Available
Description : Increased suicidal thoughts
References :

  1. Laje G, Paddock S, Manji H, Rush AJ, Wilson AF, Charney D, McMahon FJ: Genetic markers of suicidal ideation emerging during citalopram diveatment of major depression. Am J Psychiadivy. 2007 Oct;164(10):1530-8. [PubMed:17898344 ]

PMID: 28476646

Citalopram

By

Citalopram

Product: Vadadustat

Identifier : DBSNPE000047
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Glutamate receptor 3
Gene Name : GRIA3
UniProt ID : P42263
Defining Change(s) :

  • G Allele, homozygote (rs4825476 )

Allele Name : Not Available
Genotype(s) : (G;G)
Type(s) : ADR Directly Studied
Groups : Not Available
Description : Increased suicidal thoughts
References :

  1. Laje G, Paddock S, Manji H, Rush AJ, Wilson AF, Charney D, McMahon FJ: Genetic markers of suicidal ideation emerging during citalopram diveatment of major depression. Am J Psychiadivy. 2007 Oct;164(10):1530-8. [PubMed:17898344 ]

PMID: 27520483

Citalopram

By

Citalopram

Product: NS-638

Identifier : DBSNPE000072
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Multidrug resistance protein 1
Gene Name : ABCB1
UniProt ID : P08183
Defining Change(s) :

  • C Allele (rs2032583 )

Allele Name : Not Available
Genotype(s) : (C;C) / (C;T)
Type(s) : Effect Directly Studied
Groups : Not Available
Description : Improved response to antidepressant medication
References :

  1. Kato M, Fukuda T, Serretti A, Wakeno M, Okugawa G, Ikenaga Y, Hosoi Y, Takekita Y, Mandelli L, Azuma J, Kinoshita T: ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiadivy. 2008 Feb 15;32(2):398-404. Epub 2007 Sep 15. [PubMed:17913323 ]

PMID: 11504919

Citalopram

By

Citalopram

Product: Chlorotributyltin

Identifier : DBSNPE000073
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : 5-hydroxydivyptamine receptor 2A
Gene Name : HTR2A
UniProt ID : P28223
Defining Change(s) :

  • A Allele (rs7997012 )

Allele Name : Not Available
Genotype(s) : (A;A)
Type(s) : Effect Directly Studied
Groups : Not Available
Description : Improved response to antidepressant medication
References :

  1. McMahon FJ, Buervenich S, Charney D, Lipsky R, Rush AJ, Wilson AF, Sorant AJ, Papanicolaou GJ, Laje G, Fava M, Trivedi MH, Wisniewski SR, Manji H: Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant diveatment. Am J Hum Genet. 2006 May;78(5):804-14. Epub 2006 Mar 20. [PubMed:16642436 ]

PMID: 9873633

Citalopram

By

Citalopram

Product: Palmitelaidic Acid

Identifier : DBSNPE000074
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Glutamate receptor ionodivopic, kainate 4
Gene Name : GRIK4
UniProt ID : Q16099
Defining Change(s) :

  • C Allele (rs1954787 )

Allele Name : Not Available
Genotype(s) : (C;C)
Type(s) : Effect Directly Studied
Groups : Not Available
Description : Improved response to antidepressant medication
References :

  1. Paddock S, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ: Association of GRIK4 with outcome of antidepressant diveatment in the STAR*D cohort. Am J Psychiadivy. 2007 Aug;164(8):1181-8. [PubMed:17671280 ]

PMID: 9660836

Citalopram

By

Citalopram

Product: Oxyphenisatine

Identifier : DBSNPE000110
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Cyclic AMP-responsive element-binding protein 1
Gene Name : CREB1
UniProt ID : P16220
Defining Change(s) :

  • T Allele (rs4675690 )

Allele Name : Not Available
Genotype(s) : (T;T) / (C;T)
Type(s) : ADR Directly Studied
Groups : Not Available
Description : Elevated suicide risk
References :

  1. Perlis RH, Purcell S, Fava M, Fagerness J, Rush AJ, Trivedi MH, Smoller JW: Association between diveatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiadivy. 2007 Jun;64(6):689-97. [PubMed:17548750 ]

PMID: 20429916

Citalopram

By

Citalopram

Product: JNJ-42153605

Identifier : DBSNPE000111
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Cyclic AMP-responsive element-binding protein 1
Gene Name : CREB1
UniProt ID : P16220
Defining Change(s) :

  • A Allele (rs7569963 )

Allele Name : Not Available
Genotype(s) : (A;A) / (A;G)
Type(s) : ADR Directly Studied
Groups : Not Available
Description : Elevated suicide risk
References :

  1. Perlis RH, Purcell S, Fava M, Fagerness J, Rush AJ, Trivedi MH, Smoller JW: Association between diveatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiadivy. 2007 Jun;64(6):689-97. [PubMed:17548750 ]

PMID: 18295207

Citalopram

By

Citalopram

Product: Piperazine Erastin

Identifier : DBSNPE000144
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : 5-hydroxydivyptamine receptor 1A
Gene Name : HTR1A
UniProt ID : P08908
Defining Change(s) :

  • G Allele (rs6295 )

Allele Name : Not Available
Genotype(s) : (G;G)
Type(s) : Effect Directly Studied
Groups : Not Available
Description : Homozygosity for the rs6295 G allele is associated with lower response rate in patients diveated for major depression
References :

  1. Villafuerte SM, Vallabhaneni K, Sliwerska E, McMahon FJ, Young EA, Burmeister M: SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A. Psychiadiv Genet. 2009 Dec;19(6):281-91. doi: 10.1097/YPG.0b013e32832a506e. [PubMed:19829169 ]

PMID: 9632706

Citalopram

By

Citalopram

Product: RG7388

Identifier : DBSNPE004975
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Cytochrome P450 2C19
Gene Name : CYP2C19
UniProt ID : P33261
Defining Change(s) :

  • 681G>A (rs4244285 )

Allele Name : CYP2C19*2A
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional CYP2C19
Description : Poor drug metabolizer, increased risk of QT prolongation. For individual with two non-functional alleles, dose reduction or alternative drug recommended.
References :

  1. Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29. [PubMed:25974703 ]
  2. Celexa® (citalopram hydrobromide)[package insert]. Irvine, California: Allergan USA, Inc.; 2017. [Link]

PMID: 21307957

Citalopram

By

Citalopram

Product: Vortioxetine (hydrobromide)

Identifier : DBSNPE004976
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Cytochrome P450 2C19
Gene Name : CYP2C19
UniProt ID : P33261
Defining Change(s) :

  • 681G>A (rs4244285 )

Allele Name : CYP2C19*2B
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional CYP2C19
Description : Poor drug metabolizer, increased risk of QT prolongation. For individual with two non-functional alleles, dose reduction or alternative drug recommended.
References :

  1. Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29. [PubMed:25974703 ]
  2. Celexa® (citalopram hydrobromide)[package insert]. Irvine, California: Allergan USA, Inc.; 2017. [Link]

PMID: 21679703

Citalopram

By

Citalopram

Product: Vortioxetine

Identifier : DBSNPE004977
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Cytochrome P450 2C19
Gene Name : CYP2C19
UniProt ID : P33261
Defining Change(s) :

  • 636G>A (rs4986893 )

Allele Name : CYP2C19*3
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional CYP2C19
Description : Poor drug metabolizer, increased risk of QT prolongation. For individual with two non-functional alleles, dose reduction or alternative drug recommended.
References :

  1. Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29. [PubMed:25974703 ]
  2. Celexa® (citalopram hydrobromide)[package insert]. Irvine, California: Allergan USA, Inc.; 2017. [Link]

PMID: 19363060

Citalopram

By

Citalopram

Product: RG7388

Identifier : DBSNPE004975
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Cytochrome P450 2C19
Gene Name : CYP2C19
UniProt ID : P33261
Defining Change(s) :

  • 681G>A (rs4244285 )

Allele Name : CYP2C19*2A
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional CYP2C19
Description : Poor drug metabolizer, increased risk of QT prolongation. For individual with two non-functional alleles, dose reduction or alternative drug recommended.
References :

  1. Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29. [PubMed:25974703 ]
  2. Celexa® (citalopram hydrobromide)[package insert]. Irvine, California: Allergan USA, Inc.; 2017. [Link]

PMID: 21307957

Citalopram

By

Citalopram

Product: Vortioxetine (hydrobromide)

Identifier : DBSNPE004976
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Cytochrome P450 2C19
Gene Name : CYP2C19
UniProt ID : P33261
Defining Change(s) :

  • 681G>A (rs4244285 )

Allele Name : CYP2C19*2B
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional CYP2C19
Description : Poor drug metabolizer, increased risk of QT prolongation. For individual with two non-functional alleles, dose reduction or alternative drug recommended.
References :

  1. Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29. [PubMed:25974703 ]
  2. Celexa® (citalopram hydrobromide)[package insert]. Irvine, California: Allergan USA, Inc.; 2017. [Link]

PMID: 21679703

Citalopram

By

Citalopram

Product: Vortioxetine

Identifier : DBSNPE004977
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Cytochrome P450 2C19
Gene Name : CYP2C19
UniProt ID : P33261
Defining Change(s) :

  • 636G>A (rs4986893 )

Allele Name : CYP2C19*3
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional CYP2C19
Description : Poor drug metabolizer, increased risk of QT prolongation. For individual with two non-functional alleles, dose reduction or alternative drug recommended.
References :

  1. Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29. [PubMed:25974703 ]
  2. Celexa® (citalopram hydrobromide)[package insert]. Irvine, California: Allergan USA, Inc.; 2017. [Link]

PMID: 19363060

Citalopram

By

Citalopram

Product: Pafuramidine

Identifier : DBSNPE004978
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Cytochrome P450 2C19
Gene Name : CYP2C19
UniProt ID : P33261
Defining Change(s) :

  • 1A>G (rs28399504 )

Allele Name : CYP2C19*4
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional CYP2C19
Description : Poor drug metabolizer, increased risk of QT prolongation. For individual with two non-functional alleles, dose reduction or alternative drug recommended.
References :

  1. Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29. [PubMed:25974703 ]
  2. Celexa® (citalopram hydrobromide)[package insert]. Irvine, California: Allergan USA, Inc.; 2017. [Link]

PMID: 23692283

Citalopram

By

Citalopram

Product: AR-A014418

Identifier : DBSNPE004979
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Cytochrome P450 2C19
Gene Name : CYP2C19
UniProt ID : P33261
Defining Change(s) :

  • 1297C>T (rs56337013 )

Allele Name : CYP2C19*5
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional CYP2C19
Description : Poor drug metabolizer, increased risk of QT prolongation. For individual with two non-functional alleles, dose reduction or alternative drug recommended.
References :

  1. Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29. [PubMed:25974703 ]
  2. Celexa® (citalopram hydrobromide)[package insert]. Irvine, California: Allergan USA, Inc.; 2017. [Link]

PMID: 14643355

Citalopram

By

Citalopram

Product: Rocuronium (Bromide)

Identifier : DBSNPE004980
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Cytochrome P450 2C19
Gene Name : CYP2C19
UniProt ID : P33261
Defining Change(s) :

  • 395G>A (rs72552267 )

Allele Name : CYP2C19*6
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional CYP2C19
Description : Poor drug metabolizer, increased risk of QT prolongation. For individual with two non-functional alleles, dose reduction or alternative drug recommended.
References :

  1. Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29. [PubMed:25974703 ]
  2. Celexa® (citalopram hydrobromide)[package insert]. Irvine, California: Allergan USA, Inc.; 2017. [Link]

PMID: 23601187

Citalopram

By

Citalopram

Product: UPF 1069

Identifier : DBSNPE004981
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Cytochrome P450 2C19
Gene Name : CYP2C19
UniProt ID : P33261
Defining Change(s) :

  • 19294T>A (rs72558186 )

Allele Name : CYP2C19*7
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional CYP2C19
Description : Poor drug metabolizer, increased risk of QT prolongation. For individual with two non-functional alleles, dose reduction or alternative drug recommended.
References :

  1. Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29. [PubMed:25974703 ]
  2. Celexa® (citalopram hydrobromide)[package insert]. Irvine, California: Allergan USA, Inc.; 2017. [Link]

PMID: 21796211

Citalopram

By

Citalopram

Product: Vildagliptin

Identifier : DBSNPE004982
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Cytochrome P450 2C19
Gene Name : CYP2C19
UniProt ID : P33261
Defining Change(s) :

  • 557G>C (rs140278421 )
  • 991A>G

Allele Name : CYP2C19*22
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional CYP2C19
Description : Poor drug metabolizer, increased risk of QT prolongation. For individual with two non-functional alleles, dose reduction or alternative drug recommended.
References :

  1. Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29. [PubMed:25974703 ]
  2. Celexa® (citalopram hydrobromide)[package insert]. Irvine, California: Allergan USA, Inc.; 2017. [Link]

PMID: 26396690

Citalopram

By

Citalopram

Product: BMS-833923

Identifier : DBSNPE004983
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Cytochrome P450 2C19
Gene Name : CYP2C19
UniProt ID : P33261
Defining Change(s) :

  • 99C>T (rs17885098 )
  • 991A>G (rs3758581 )
  • 1004G>A (rs118203757 )
  • 1197A>G

Allele Name : CYP2C19*24
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional CYP2C19
Description : Poor drug metabolizer, increased risk of QT prolongation. For individual with two non-functional alleles, dose reduction or alternative drug recommended.
References :

  1. Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29. [PubMed:25974703 ]
  2. Celexa® (citalopram hydrobromide)[package insert]. Irvine, California: Allergan USA, Inc.; 2017. [Link]

PMID: 20394377

Citalopram

By

Citalopram

Product: PJ34

Identifier : DBSNPE004984
Drug : DB00215 (Citalopram)
Interacting Gene/Enzyme : Cytochrome P450 2C19
Gene Name : CYP2C19
UniProt ID : P33261
Defining Change(s) :

  • 12662A>G (rs12769205 )

Allele Name : CYP2C19*35
Genotype(s) : Not Available
Type(s) : ADR Inferred
Groups : Non-functional CYP2C19
Description : Poor drug metabolizer, increased risk of QT prolongation. For individual with two non-functional alleles, dose reduction or alternative drug recommended.
References :

  1. Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29. [PubMed:25974703 ]
  2. Celexa® (citalopram hydrobromide)[package insert]. Irvine, California: Allergan USA, Inc.; 2017. [Link]

PMID: 23690594

By

Related Post

You Missed

Uncategorized

CaMKII-IN-1

Uncategorized

Lithocholic acid

Uncategorized

Gatifloxacin mesylate

Uncategorized

Irbesartan